Project Grant K99AI180360
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$115K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This $639,485 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the mechanisms of STAT1 and STAT3 activation and nuclear translocation in immune cell signaling. The research aims to decipher how activated STAT1 and STAT3 enter the cell nucleus and how gain-of-function mutations in these transcription factors impact their nuclear signaling and contribute...
This federal Project Grant award, with an ID of K08AI182483, is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The total funding amount is $195,894.00 over the award period from August 6, 2024 to July 31, 2029. The primary objective of this grant is to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function syndrome, a primary immune regulatory disorder. The research...
This Project Grant award, valued at $550,375, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports scientific research at the University of Chicago focused on understanding the role of the BATF transcription factor in regulating natural killer (NK) cell expansion and effector function. Specifically, the research aims to investigate the consequences of altered BATF expression on...
This $256,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research by the Fred Hutchinson Cancer Center in Seattle, Washington, to investigate how regulatory T cells coordinate the mucosal natural killer (NK) cell response during viral infections. The key objectives are to gain a deeper understanding of how regulatory T cells modulate NK cell function and homing...
This $189,713 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of the PIM1 kinase in regulating the metabolic adaptation of effector CD8 T cells during chronic viral infection. The research aims to elucidate how the IL-21-PIM1 signaling axis governs the metabolic programs of late-stage effector T cells and enables their...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $142,908 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the San Diego Biomedical Research Institute. The funding supports research to determine how antibody glycosylation influences natural killer (NK) cell activation and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection. Specifically, the project aims to 1) examine how monoclonal antibody glycosylation profiles...
This $879,200 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how the transcription factor PLZF, which is critical for the development and function of invariant natural killer T cells, requires the co-factor YY1 to operate. The research aims to elucidate the mechanisms by which the ubiquitously expressed YY1 regulates the lineage-specific...
This Project Grant award of $478,800.00 was issued on June 17, 2024 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant funds the development of "phosphorylation editing chimeras" - small molecules that can induce protein phosphorylation by recruiting kinases to target proteins. The goal is to create a new class of molecules that can activate, inhibit, or modify protein function through...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 in funding to support research into the role of cell, antigen, and antibody in controlling virus infection through Fc-dependent mechanisms. The key objectives of this 5-year project are to: Assess the molecular determinants that govern how natural killer (NK) cells control virus dissemination through...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides funding of $857,346.00 to the Fred Hutchinson Cancer Center in Seattle, Washington. The award supports research to investigate how activating and inhibitory signals, such as cytokines and metabolites, regulate the function of CD8 T cells in healthy and infected human tissues. The goal is to better understand how immune...